Cite
HARVARD Citation
Ota, D. et al. (n.d.). 1853 Phase I study of combination therapy with weekly nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with advanced or recurrent breast cancer. European journal of cancer. pp. S283-. [Online].